Zimmer Biomet Shares Drop Despite Profit Forecast Raise
The medical device maker maintained its annual revenue outlook amid a U.S. sales force transition. Shares fell 7% today despite a raised full-year profit forecast.
Xurve View
Insights:
Xurve View
ZIMMER BIOMET HOLDINGS INC shares fell 7% Tuesday after the medical device maker maintained its 1% to 3% revenue growth forecast for 2026. The cautious outlook follows a United States sales force overhaul that caused the loss of two large customer accounts this quarter. Investors are weighing a $0.10 raise in profit guidance against execution risks as the company restructures its commercial model.
